NaNose Medical

NaNose MedicalNaNose Medical
NaNose Medical

NaNose Medical

Leveraging nanotechnology and AI for early disease detection and improved healthcare.

Website
DR 132017Active15Tel Aviv, Israel
Rate
Advertise here

About

NaNose Medical develops non-invasive, AI-driven sensing technology for early disease diagnosis and management using breath biomarkers. Their portable handheld device, Dianose, offers rapid, accurate, and affordable screening for conditions like chronic liver disease (ReLiV) and lung cancer (LUCIA). The company serves patients and healthcare professionals by enabling early action and intensive monitoring to improve outcomes and save lives.
Frequently asked

What does NaNose Medical do?

NaNose Medical develops non-invasive, AI-driven sensing technology for early disease diagnosis and management using breath biomarkers. Their portable handheld device, Dianose, offers rapid, accurate, and affordable screening for conditions like chronic liver disease (ReLiV) and lung cancer (LUCIA). The company serves patients and healthcare professionals by enabling early action and intensive monitoring to improve outcomes and save lives.

What is NaNose Medical's revenue?

StartupHub estimates NaNose Medical's annual revenue at $2.5M (range $1.5M to $3.9M, 66% confidence), based on comparable companies in the sector.

Where is NaNose Medical headquartered?

NaNose Medical is headquartered in Tel Aviv, Israel.

When was NaNose Medical founded?

NaNose Medical was founded in 2017.

What industry does NaNose Medical operate in?

NaNose Medical operates in Healthcare, Medical Devices, Artificial Intelligence, HealthTech, MedTech, Nanotechnology.

How many employees does NaNose Medical have?

NaNose Medical has approximately 15 people on record.

HEADCOUNT
15
DOMAIN RATING
13
Comments

No comments yet. Be the first to share your take.